-
INTEGRATING GENERATIVE ARTIFICIAL INTELLIGENCE (AI) INTO BIOSTATISTICAL WORKFLOWS FOR TRIAL EMULATION: A FRAMEWORK TO ACCELERATE REAL-WORLD EVIDENCE GENERATION
Feb 25, 2026, 14:41 PM -
EXPLORATORY APPLICATION OF BIVARIATE NETWORK META-ANALYSIS TO PREDICT MISSING HAZARD RATIOS IN MCRPC USING SIMULATED CORRELATION DATA
Feb 25, 2026, 14:41 PM -
FROM NATURAL HISTORY TO POST-APPROVAL EVIDENCE: AN INTEGRATED MULTI-SOURCE REAL-WORLD PROGRAM CHARACTERIZING IGA NEPHROPATHY IN THE ERA OF ORAL TARGETED-RELEASE FORMULATION OF BUDESONIDE
Feb 25, 2026, 14:41 PM -
ESTIMATING HETEROGENEOUS TREATMENT EFFECTS FOR PHARMACOEPIDEMIOLOGIC STUDIES: A SCOPING REVIEW FOR CAUSAL FOREST MODELS
Feb 25, 2026, 14:41 PM -
IMPACT OF LUPUS NEPHRITIS FLARES ON HEALTHCARE UTILIZATION: A RETROSPECTIVE COHORT STUDY IN THE UNITED STATES BETWEEN 2016 AND 2025
Feb 25, 2026, 14:41 PM -
DECOMPOSITION OF GEOGRAPHIC VARIATION IN HEALTHCARE SPENDING
Feb 25, 2026, 14:41 PM -
ASSESSING TRADE-OFFS IN SCHIZOPHRENIA TREATMENT: A MULTI-CRITERIA DECISION ANALYSIS OF PALIPERIDONE FORMULATIONS
Feb 25, 2026, 14:41 PM -
A MOSAIC OF EVIDENCE: THE CLINICAL AND ECONOMIC BENEFITS OF CERAMIDE-INFUSED SKIN BARRIERS IN OSTOMY CARE
Feb 25, 2026, 14:41 PM -
COMPARATIVE POST-MARKETING SAFETY STUDY OF NIRSEVIMAB AND PALIVIZUMAB: A PHARMACOVIGILANCE ANALYSIS USING FAERS AND WHO VIGIACCESS
Feb 25, 2026, 14:41 PM -
IMPROVING AN ADHERENT PATIENT ANALYSIS OF THE DIABETES PREVENTION PROGRAM AND OUTCOMES STUDY
Feb 25, 2026, 14:41 PM -
DOES LONG-TERM EXPOSURE TO OPIOID LEAD TO HIGHER RISK OF BREAST CANCER RECURRENCE? AN OBSERVATIONAL STUDY USING U.S. POPULATION DATA
Feb 25, 2026, 14:41 PM -
HOSPITALIZED PATIENT WITH ASTHMA IN JORDAN: A CLINICAL AND ECONOMIC INVESTIGATION
Feb 25, 2026, 14:41 PM -
AI-POWERED NLP FOR COMPREHENSIVE IBD PHENOTYPING ENTITY AND RELATIONSHIP EXTRACTION OF CLINICAL FEATURES AND BIOMARKERS FROM EHR
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS IN ADULTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA: A U.S. PAYER PERSPECTIVE MARKOV MODEL
Feb 25, 2026, 14:41 PM -
BREAST CANCER ( BC ). AN ANALYSIS OF COST VARIABILITY (CV ) BASED ON MOLECULAR SUBTYPE
Feb 25, 2026, 14:41 PM -
ENSURING ESTIMAND AND POPULATION CONSISTENCY ACROSS HEALTH TECHNOLOGY ASSESSMENT DOSSIER COMPONENTS
Feb 25, 2026, 14:41 PM -
A PILOT ASSESSMENT OF LLM-GENERATED SYNTHETIC COHORTS: A FIRST STEP TOWARD ROBUST SYNTHETIC CONTROL ARMS
Feb 25, 2026, 14:41 PM -
THE FEASIBILITY OF MEASURING BTKI MEDICATION ADHERENCE IN THE TREATMENT OF CLL/SLL USING AN ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) PLATFORM
Feb 25, 2026, 14:41 PM -
OBJECT-CENTRIC CAUSAL DISCOVERY IN MIMIC-IV: A PARADIGM SHIFT FOR IDENTIFYING RISK FACTORS FOR HOSPITAL-ACQUIRED PRESSURE INJURIES IN REAL-WORLD CLINICAL DATA
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF NEOADJUVANT AND ADJUVANT PEMBROLIZUMAB IN LOCALLY ADVANCED HEAD AND NECK CANCER
Feb 25, 2026, 14:41 PM
